Nicotinell Icemint (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Icemint, is a nicotine replacement therapy presented as a buccal delivery system for buccal use. It helps adult smokers who want to quit by reducing nicotine withdrawal symptoms and cravings. GNH USA supplies Nicotinell Icemint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Icemint is a nicotine replacement product that acts on the nicotine dependence pathway to aid smoking cessation.

- Smoking cessation: helps adult smokers reduce withdrawal symptoms and gradually discontinue tobacco use.

Nicotinell Icemint may cause a range of adverse reactions. Most are mild and resolve with continued use.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: occasional scratchy feeling. - Nausea: transient upset stomach. - Hiccups: brief episodes during or after use. - Headache: mild to moderate intensity. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Chest pain: unexpected discomfort that may indicate cardiac stress. - Irregular heartbeat: palpitations or arrhythmia. - Severe mouth sores: ulceration that persists. - Persistent vomiting: inability to keep fluids down. - Elevated blood pressure: sustained hypertension.

Before using Nicotinell Icemint, consider the following safety measures. - Assess nicotine dependence: determine the appropriate starting strength. - Contraindication: avoid if known hypersensitivity to nicotine or excipients. - Cardiovascular risk: monitor patients with heart disease or hypertension. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicotinell Icemint can interact with other substances that affect nicotine levels or cardiovascular function.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Concurrent nicotine replacement products: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., certain antiretrovirals): may alter nicotine metabolism. - Antidepressants (SSRIs, SNRIs): may enhance dizziness or nausea. - Alcohol: can increase nicotine cravings and side‑effect intensity.